Related Experiment Video
Updated: May 18, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
A novel accessory molecule Trim59 involved in cytotoxicity of BCG-activated macrophages
Xiangfeng Zhao1, Qihui Liu, Baiqiu Du
1Department of Immunology, Norman Bethune College of Medicine, Jilin University, Changchun, 130021, China. zxf184@163.com
Abstract:
BCG-activated macrophages (BAM) could kill the tumor cells through cell-cell contact. In this process membrane proteins play an important role. However, up to date, few membrane proteins were revealed. In this study, we selected a surface molecule named Trim59, which was specifically expressed on BAM membrane (compared with the negative control). We cloned and prokaryoticly expressed the extracellular domain of Trim59, purified the recombinant protein and generated polyclonal antibodies. Immunohistochemistry showed that Trim59 abundantly expressed in spleen, stomach and ovary; intermediately expressed in brain, lung, kidney, muscle and intestine; but not in thymus, liver, heart, uterus. Using the antibodies to block Trim59 on BAM significantly reduced BAM cytotoxicity against MCA207 cells. This demonstrated that Trim59 serves as an indispensable molecule in maintaining BAM activity. Overexpression of Trim59 in Raw264.7 cell line failed to lyse target MCA207 cells, which potentiated Trim59 per se could not enhance macrophage cytotoxicity; on another hand, overexpression of Trim59 enhance the pinocytosis and Phagocytosis activity of Raw-264.7, which imply Trim59 might mediate the cell-molecule interaction. Our results indicate Trim59 might be an essential accessory molecule in mediating BAM tumoricidal functions; and Trim59 is a phagocytosis-correlated molecule.
Insights
Trim59 is a membrane protein crucial for BCG-activated macrophage (BAM) tumoricidal activity. Blocking Trim59 significantly reduced BAM
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- BCG-activated macrophages (BAM) exhibit tumoricidal activity via cell-cell contact.
- Membrane proteins play a vital role in macrophage-mediated cytotoxicity, but few have been identified.
- Trim59 was identified as a surface molecule specifically expressed on BAM membranes.
Purpose of the Study:
- To investigate the role of Trim59 in BAM-mediated tumor cell killing.
- To characterize the expression pattern of Trim59.
- To elucidate the function of Trim59 in macrophage activity.
Main Methods:
- Cloning and prokaryotic expression of the extracellular domain of Trim59.
- Purification of recombinant Trim59 protein and generation of polyclonal antibodies.
- Immunohistochemistry to determine Trim59 expression in various tissues.
- In vitro assays to assess the effect of Trim59 blockade on BAM cytotoxicity and macrophage phagocytosis.
Main Results:
- Trim59 is abundantly expressed in spleen, stomach, and ovary; intermediately in brain, lung, kidney, muscle, and intestine; and absent in thymus, liver, heart, and uterus.
- Antibody-mediated blockade of Trim59 significantly reduced BAM cytotoxicity against MCA207 tumor cells.
- Overexpression of Trim59 enhanced pinocytosis and phagocytosis in Raw264.7 cells, but did not directly lyse tumor cells.
- Trim59 appears to be an accessory molecule mediating BAM tumoricidal functions and is correlated with phagocytosis.
Conclusions:
- Trim59 is an indispensable molecule for maintaining the tumoricidal activity of BCG-activated macrophages.
- Trim59 plays a role in mediating cell-molecule interactions, enhancing phagocytosis.
- Trim59 is a significant contributor to macrophage-based anti-tumor functions.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018